机构：[1]Institute of Precision Cancer Medicine and Pathology, And Department of Pathology, School of Medicine, And Minister of Education Key Laboratory of Tumor Molecular[2]Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China[3]Cancer Research Center, Shantou University Medical College, Shantou, Guangdong, China[4]Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, China[5]Department of Urology Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China[6]Department of Oncology, People’s Hospital of Leshan, Leshan, Sichuan, China[7]Health Care Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China[8]Department of Pathology, Gongli Hospital, Naval Medical University, Shanghai, China[9]Department of Pathology, Heping Hospital, Changzhi Medical College, Changzhi, Shanxi, China[10]Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China[11]Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China[12]Department of Central Laboratory, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China[13]Department of Clinical Laboratory, The Fifth Affiliated Hospital of Jinan University (Heyuan Shenhe People’s Hospital), Heyuan, Guangdong, China[14]Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China[15]MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center of Nanjing University, Nanjing, Jiangsu, China[16]Department of Biomedical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA[17]College of Clinical Medicine, The First Affiliated Hospital of Henan University of Science and Technology, Henan Key Laboratory of Cancer Epigenetics, Luoyang,[18]Department of Emergency Medicine, University of Texas MD Anderson Cancer Center and Department of Endocrine Neoplasia and Hormonal Disorders, University of
This work was partially supported by the
National Natural Science Foundation of China (82072683, 81773087,
81071736, 81572876 and 30973508 to HZ, 81802404 to HD), the
Natural Science Foundation of Guangdong Province of China
(2021A1515012522, 9151018004000000 and 2022A1515010925 to HZ, 2021A1515011028 and 2022A1515011739 to HD); Science and
Technology Planning Project of Guangdong Province of China
(2019A030317024 to HZ); Special Project on the Integration of Industry, Education and Research of Guangdong Province
(2011A090100024 to HZ); Jinan university Innovation and Entrepreneurship Fund for College Students (202110559097 and 202210559081
to HZ); Flagship specialty construction project General surgery (grant
No.: 711003), and the Shantou University-Technion Research Program
(grant No. 43209504 to HZ).
第一作者机构：[1]Institute of Precision Cancer Medicine and Pathology, And Department of Pathology, School of Medicine, And Minister of Education Key Laboratory of Tumor Molecular[2]Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China
共同第一作者：
通讯作者：
通讯机构：[2]Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China[17]College of Clinical Medicine, The First Affiliated Hospital of Henan University of Science and Technology, Henan Key Laboratory of Cancer Epigenetics, Luoyang,[18]Department of Emergency Medicine, University of Texas MD Anderson Cancer Center and Department of Endocrine Neoplasia and Hormonal Disorders, University of[*1]Department of General Surgery, The First Affliated Hospital of Jinan University, 613 Huangpu Avenue West, Guangzhou, Guangdong, 510630,China.[*2]College of Clinical Medicine, The First Affiliated Hospital of Henan University of Science and Technology, Henan Key Laboratory of Cancer Epigenetics, Luoyang, 471000, Henan, China.[*3]Department of Emergency Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
推荐引用方式(GB/T 7714)：
Dong Hongmei,Lin Wan,Du Liang,et al.PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET[J].CANCER LETTERS.2023,567:doi:10.1016/j.canlet.2023.216283.
APA：
Dong Hongmei,Lin Wan,Du Liang,Yao Zhimeng,Li Feifei...&Zhang Hao.(2023).PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET.CANCER LETTERS,567,
MLA：
Dong Hongmei,et al."PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET".CANCER LETTERS 567.(2023)
医学